title: Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke.
abstract: To investigate the temporal expressions of IL-9 and its related cytokines after middle cerebral artery occlusion in rats. IL-9 and its related cytokines in ischemia brain and blood were tested after rats were subjected to transient focal ischemia. Comparing with sham-operated group, the levels of IL-4, TGF-β, PU.1, IRF4, OX40, NIK, RelB-p52 and IL-9 in experimental groups were significantly higher after middle cerebral artery occlusion. The results showed that expressions of IL-9 and its upstream stimulating factors increased in experimental stroke, and whether they play a role or just a secondary change is awaiting further research.
authors: Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, Guangdong, China.
authors: Yinyao
authors: Y
authors: Lin
authors: Lei
authors: L
authors: Zhang
authors: Yongqiang
authors: Y
authors: Dai
authors: Haiyan
authors: H
authors: Li
authors: Yanqiang
authors: Y
authors: Wang
authors: Bingjun
authors: B
authors: Zhang
authors: Suqin
authors: S
authors: Chen
authors: Zhengqi
authors: Z
authors: Lu
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism*; D004195:Disease Models, Animal; D020244:Infarction, Middle Cerebral Artery / Q000378:metabolism; D016906:Interleukin-9 / Q000378:metabolism*; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000378:metabolism; D020521:Stroke / Q000378:metabolism*
chemical_list: D016207:Cytokines; D016906:Interleukin-9; D012333:RNA, Messenger
references: Eur J Pharmacol. 2013 Aug 15;714(1-3):303-11
references: 23911884
references: Nat Immunol. 2010 Jun;11(6):527-34
references: 20431622
references: J Cereb Blood Flow Metab. 1994 Jul;14(4):697-8
references: 7516936
references: J Allergy Clin Immunol. 2003 Jun;111(6):1319-27
references: 12789235
references: Stroke. 1989 Jan;20(1):84-91
references: 2643202
references: Trends Immunol. 2011 Apr;32(4):146-50
references: 21371941
references: Stroke. 1997 Jun;28(6):1233-44
references: 9183357
references: Stroke. 2011 Dec;42(12):3651-4
references: 22052510
references: Neuroreport. 1998 Jun 22;9(9):2131-4
references: 9674607
references: J Neurol. 2011 Apr;258(4):677-85
references: 21424610
references: J Allergy Clin Immunol. 2011 Dec;128(6):1357-1360.e5
references: 21798577
references: J Immunol. 2011 Apr 1;186(7):4415-21
references: 21346235
references: Int Immunol. 2013 Oct;25(10):547-51
references: 24027199
references: Nat Rev Immunol. 2002 Dec;2(12):933-44
references: 12461566
references: J Immunol. 2009 Dec 1;183(11):7169-77
references: 19890056
references: Int Immunol. 2007 Jan;19(1):1-10
references: 17101709
references: Brain Res. 2008 Jan 2;1187:20-32
references: 18035338
references: Cell. 2000 Mar 17;100(6):655-69
references: 10761931
references: Cell. 2008 May 30;133(5):775-87
references: 18510923
references: J Allergy Clin Immunol. 2011 Jul;128(1):234-237.e7
references: 21439621
references: J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):108-15
references: 10629460
references: Am J Respir Crit Care Med. 2002 Aug 1;166(3):409-16
references: 12153980
references: J Cereb Blood Flow Metab. 1999 Aug;19(8):819-34
references: 10458589
references: Stroke. 1995 Apr;26(4):676-80; discussion 681
references: 7709417
references: Annu Rev Immunol. 2006;24:607-56
references: 16551261
references: J Neuropathol Exp Neurol. 2003 Feb;62(2):127-36
references: 12578222
references: Annu Rev Immunol. 2007;25:821-52
references: 17201677